Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Arcus Biosciences (NYSE: RCUS ) initiated with Buy rating and $22 (150% upside) price target at Mizuho Securities. More news on: Arcus Biosciences, Inc., Stealth BioTherapeutics Corp, HOOKIPA Pharma Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Christine D. Baker has joined as Chief Business Officer Roman Necina, PhD, will join as Chief Technology Officer NEW YORK and VIENNA, Austria, Sept. 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class o...
NEW YORK and VIENNA, Austria, Sept. 19, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platforms, will present the anti...
NEW YORK and VIENNA, Austria, Aug. 29, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HO...
HOOKIPA Pharma (NASDAQ: HOOK ): Q2 Net loss of $12.08M. More news on: HOOKIPA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NEW YORK and VIENNA, Austria, Aug. 12, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform, today reported recent ...
Hookipa Pharma ( HOOK ) announced that an IND was cleared by the FDA so that it could begin its phase 1/2 study treating patients with Human Papilloma Virus ((HPV))-positive cancers. The reason why this latest development is important for the biotech is because it will be the first immuno-on...
The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) took a steep hit last week, crashing from 3,422.32 points on Monday’s (July 8) open to 3,315.46 points as of 1:32 p.m. EDT on Friday (July 12). A likely catalyst for the index’s crash was US President Donald Trump’s pled...
Gainers : Tower International (NYSE: TOWR ) +69% . Camber Energy (NYSEMKT: CEI ) +50% . HOOKIPA Pharma (NASDAQ: HOOK ) +28% . Milacron Holdings (NYSE: MCRN ) +25% . VivoPower International PLC (NASDAQ: VVPR ) +21% . ProQR Therapeutics N.V. (NASDAQ: PRQR ) +21% . Oasmi...
News, Short Squeeze, Breakout and More Instantly...
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential...
A look at the top 10 most actives in the United States Longeveron Inc. (LGVN) rose 69.0% to $4.8499 on volume of 46,980,986 shares Virpax Pharmaceuticals Inc. (VRPX) rose 161.5% to $3.0333 on volume of 46,199,502 shares Maxeon Solar Technologies Ltd. (MAXN) fell 0.6% to $0.2464 on volume ...
2024-07-09 09:02:05 ET Hookipa Pharma Inc (HOOK) announced stock split at a ratio of 1-for-10 on 2024-07-10 ... Full story available on KlickAnalytics.com